OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
10
Results
Show all
Save search
Copy query
Show results for
Unknown
(10)
Release Date
2025
(4)
2026
(1)
2024
(1)
2021
(1)
2020
(1)
2018
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Gualou Xiebai Decoction, a Traditional Chinese Medicine, Prevents Cardiac Reperfusion Injury of Hyperlipidemia Rat via Energy Modulation.
Not available
S-EPMC5895855
|
biostudies-literature
Cite
The Taiwan Precision Medicine Initiative provides a cohort for large-scale studies.
Not available
S-EPMC12675286
|
biostudies-literature
Cite
Ultrahigh-energy gamma-ray emission associated with black hole-jet systems.
Not available
S-EPMC12746838
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Robust estimation of bacterial cell count from optical density.
Not available
S-EPMC7499192
|
biostudies-literature
Cite
Polygenic prediction of body mass index and obesity through the life course and across ancestries.
Not available
S-EPMC12443623
|
biostudies-literature
Cite
Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study.
Not available
S-EPMC7880913
|
biostudies-literature
Cite
Observation of quantum entanglement with top quarks at the ATLAS detector.
Not available
S-EPMC11410654
|
biostudies-literature
Cite
Transforming jet flavour tagging at ATLAS.
Not available
S-EPMC12804921
|
biostudies-literature
Cite
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets